title: Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis?
authors.forename: Jiannis
authors.initials: J
authors.lastname: Vlachogiannakos
authors.forename: George
authors.initials: G
authors.lastname: Daikos
authors.forename: Ulrich
authors.initials: U
authors.lastname: Thalheimer
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
authors.forename: Spiros D
authors.initials: SD
authors.lastname: Ladas
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D018988:Bacterial Translocation / Q000502:physiology*; D015415:Biomarkers / Q000097:blood; D004269:DNA, Bacterial / Q000097:blood*; D004731:Endotoxins / Q000097:blood*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology*; D012189:Retrospective Studies; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D012720:Severity of Illness Index
chemical_list: D000890:Anti-Infective Agents; D015415:Biomarkers; D004269:DNA, Bacterial; D004731:Endotoxins; D012294:Rifamycins; D000078262:Rifaximin